» Articles » PMID: 39247361

Insight into Structural Dynamics Involved in Activation Mechanism of Full Length KRAS Wild Type and P-loop Mutants

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Sep 9
PMID 39247361
Authors
Affiliations
Soon will be listed here.
Abstract

KRAS protein is known to be frequently mutated in various cancers. The most common mutations being at position 12, 13 and 61. The positions 12 and 13 form part of the phosphate binding region (P-loop) of KRAS. Owing to mutation, the protein remains in continuous active state and affects the normal cellular process. Understanding the structural changes owing to mutations in GDP-bound (inactive state) and GTP-bound (active state) may help in the design of better therapeutics. To understand the structural flexibility due to the mutations specifically located at P-loop regions (G12D, G12V and G13D), extensive molecular dynamics simulations (24 μs) have been carried for both inactive (GDP-bound) and active (GTP-bound) structures for the wild type and these mutants. The study revealed that the local structural changes at the site of mutations allosterically guide changes in distant regions of the protein through hydrogen bond and hydrophobic signalling network. The dynamic cross correlation analysis and the comparison of the correlated motions among different systems manifested that changes in SW-I, SW-II, α3 and the loop preceding α3 affects the interactions of GDP/GTP with different regions of the protein thereby affecting its hydrolysis. Further, the Markov state modelling analysis confirmed that the mutations, especially G13D imparts rigidity to structure compared to wild type and thus limiting its conformational state in either intermediate state or active state. The study suggests that along with SW-I and SW-II regions, the loop region preceding the α3 helix and α3 helix are also involved in affecting the hydrolysis of nucleotides and may be considered while designing therapeutics against KRAS.

Citing Articles

Deciphering allosteric mechanisms in KRAS activation: insights from GTP-induced conformational dynamics and interaction network reorganization.

Zhao D, Yang J, Liu M, Yang L, Sang P RSC Adv. 2025; 15(3):2261-2274.

PMID: 39850080 PMC: 11755325. DOI: 10.1039/d4ra07924h.

References
1.
Kearney B, Johnson C, Roberts D, Swartz P, Mattos C . DRoP: a water analysis program identifies Ras-GTP-specific pathway of communication between membrane-interacting regions and the active site. J Mol Biol. 2013; 426(3):611-29. DOI: 10.1016/j.jmb.2013.10.036. View

2.
Khaled M, Gorfe A, Sayyed-Ahmad A . Conformational and Dynamical Effects of Tyr32 Phosphorylation in K-Ras: Molecular Dynamics Simulation and Markov State Models Analysis. J Phys Chem B. 2019; 123(36):7667-7675. PMC: 7020251. DOI: 10.1021/acs.jpcb.9b05768. View

3.
Wang X, Allen S, Blake J, Bowcut V, Briere D, Calinisan A . Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS Inhibitor. J Med Chem. 2021; 65(4):3123-3133. DOI: 10.1021/acs.jmedchem.1c01688. View

4.
Hunenberger P, Mark A, van Gunsteren W . Fluctuation and cross-correlation analysis of protein motions observed in nanosecond molecular dynamics simulations. J Mol Biol. 1995; 252(4):492-503. DOI: 10.1006/jmbi.1995.0514. View

5.
Li L, Liu J, Yang Z, Zhao H, Deng B, Ren Y . Discovery of Thieno[2,3-d]pyrimidine-based KRAS G12D inhibitors as potential anticancer agents via combinatorial virtual screening. Eur J Med Chem. 2022; 233:114243. DOI: 10.1016/j.ejmech.2022.114243. View